Hot Topics

News

Penn Spinout Verismo Therapeutics Raises $16M to Advance Cell Therapies

Cellular therapy in preclinical development to target pancreatic cancer, mesothelioma and ovarian cancer.

Read more
News

Dr. Carl June Receives Leadership in Personalized Medicine Award

Personalized Medicine Coalition award recognizes new era in precision medicine with treatments characterized by ability to alter molecular characteristics of patients’ own cells.

Read more
Info

Research Lab Update

Update March 18: Message to PLM Research Faculty: NIH COVID-19 announcements and PSOM-mandated lab ramp-down.

Read more
Info

Research Lab Update

Update March 16: Message to PLM Research Faculty regarding lab ramp-down as mandated by PSOM leadership.

Read more
News

CRISPR-engineered T cells in Patients with Refractory Cancer

Genetically-edited immune cells can persist, thrive, and function months after a cancer patient receives them, according to new data published in Science by researchers from the Abramson Cancer Center.

Read more
publication

CRISPR-engineered T cells in patients with refractory cancer

Genetically-edited immune cells can persist, thrive, and function months after a cancer patient receives them, according to new data published by researchers from the Abramson Cancer Center.

Read more